Justin S. Golub
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Justin S. Golub has a total of 170 co-authors. Here are the top co-authors by number of shared publications:
Alexander Chern
Department of Otolaryngology‐Head and Neck Surgery Johns Hopkins Hospital Baltimore Maryland USA
8 shared publications- Michael W. Denham
Department of Otolaryngology—Head and Neck Surgery, Columbia University Vagelos College of Physicians and Surgeons New York‐Presbyterian/Columbia University Irving Medical Center New York New York USA
7 shared publications Lauren H. Tucker
6 shared publicationsMaeher R. Grewal
Department of Otolaryngology‐Head and Neck Surgery University of Utah Health Salt Lake City Utah USA
6 shared publicationsAdam M. Brickman
Vagelos College of Physicians and Surgeons, Columbia University
5 shared publicationsAlexandria L. Irace
Department of Otolaryngology–Head and Neck Surgery, Columbia University Vagelos College of Physicians and Surgeons, NewYork-Presbyterian/Columbia University Irving Medical Center, New York, New York
5 shared publications
Latest Publications
- Open Access
- 22 July 2026
- Published by Springer Nature
- p. 389-399
Instrumentation in Otologic and Neurotologic Surgery
Surgical instrumentation and equipment are nearly as important as surgical technique. In otologic surgery, instruments are nuanced and, in some cases, nearly indistinguishable from each other without magnification. A variety of different instruments are available to help facilitate successful surgery, including dissectors, retractors, hemostatic agents, and lasers. This chapter focuses on some of the most commonly used tools in otologic surgery.
- 22 July 2026
- Published by Springer Nature
- p. 389-399
Open AccessInstrumentation in Otologic and Neurotologic Surgery
Surgical instrumentation and equipment are nearly as important as surgical technique. In otologic surgery, instruments are nuanced and, in some cases, nearly indistinguishable from each other without magnification. A variety of different instruments are available to help facilitate successful surgery, including dissectors, retractors, hemostatic agents, and lasers. This chapter focuses on some of the most commonly used tools in otologic surgery.
- Open Access
- 16 June 2026
- Published by JMIR Publications Inc. in JMIR Aging
- Vol. 9 (1) , e84083
Web-Based Gamified Auditory-Cognitive Dual-Task Training for Older Adults With Age-Related Hearing Loss: Pilot Randomized Controlled Trial
Background: Everyday listening ability is essential for individual health and well-being. Age-related hearing loss (ARHL) is associated with reduced communication engagement, social isolation, loneliness, cognitive decline, and increased dementia risk. Interventions that simultaneously target auditory processing and cognitive function, particularly within engaging and ecologically valid contexts, may offer greater benefits than unimodal approaches. However, culturally adapted, web-based, gamified auditory-cognitive dual-task training (ACDT) tailored for older adults with ARHL remains underexplored. At the time of this writing, few auditory or auditory-cognitive training programs are available in Chinese languages, creating linguistic and cultural barriers for older adults. Objective: This study aimed to (1) assess the feasibility and acceptability of home-based ACDT among older Chinese adults with ARHL and (2) examine its preliminary effects on global cognition, hearing, social engagement, and loneliness. It was hypothesized that the intervention group would demonstrate greater improvements in global cognition, hearing, and social engagement than the control group. Methods: Sixty community-dwelling older adults with mild-to-moderate ARHL were randomized 1:1 to either the ACDT group or a waitlist control group in a single-blinded pilot randomized controlled trial. Demographic data and outcome measures were collected at baseline, week 6, and week 12. Postintervention interviews were conducted to assess the feasibility and acceptability of ACDT. Results: A total of 60 participants were randomized (mean age 67.65, SD 4.78 years; 45/60, 75% male). ACDT demonstrated high feasibility and acceptability. The ACDT group showed significant improvements in focused attention (mean change=–0.15; P=. 02; d =–0.46) and divided attention (mean change=–0.21; P=. 002; d =–0.63). Significant cognitive improvements on the Hong Kong-Montreal Cognitive Assessment were identified in naming ( r =0.37; P=. 05) and visual cognition ( r =0.44; P=. 02) in the intervention group, while no significant improvements were found in the control group. Both groups reported significant decreases in emotional hearing handicap, with slightly greater improvement in the intervention group ( r =0.39; P=. 03) than in the control group ( r =0.37; P=. 04). Linear mixed model analysis revealed a small to moderate group effect (Cohen d =0.38) for 5-minute delayed recall on the Auditory Verbal Learning Test, with the fixed effects explaining 69% of the variance (marginal R² =0.69). A significant time×group interaction was observed for left-ear thresholds ( P=. 01). Qualitative analysis identified three key themes: (1) intervention coherence and participants’ affective attitude toward ACDT; (2) perceived benefits in cognition, information acquisition, and self-awareness from ACDT; and (3) perceiving ACDT as less burdensome with enhanced self-efficacy. Conclusion: Future iterations should incorporate artificial intelligence–enhanced personalization. Large-scale randomized controlled trials involving diverse samples and active control conditions are needed to confirm sustained effects on auditory and cognitive health, dual-task listening-cognitive abilities, and real-world functioning.
- 16 June 2026
- Published by JMIR Publications Inc. in JMIR Aging
- Vol. 9 (1) , e84083
Open AccessWeb-Based Gamified Auditory-Cognitive Dual-Task Training for Older Adults With Age-Related Hearing Loss: Pilot Randomized Controlled Trial
Background: Everyday listening ability is essential for individual health and well-being. Age-related hearing loss (ARHL) is associated with reduced communication engagement, social isolation, loneliness, cognitive decline, and increased dementia risk. Interventions that simultaneously target auditory processing and cognitive function, particularly within engaging and ecologically valid contexts, may offer greater benefits than unimodal approaches. However, culturally adapted, web-based, gamified auditory-cognitive dual-task training (ACDT) tailored for older adults with ARHL remains underexplored. At the time of this writing, few auditory or auditory-cognitive training programs are available in Chinese languages, creating linguistic and cultural barriers for older adults. Objective: This study aimed to (1) assess the feasibility and acceptability of home-based ACDT among older Chinese adults with ARHL and (2) examine its preliminary effects on global cognition, hearing, social engagement, and loneliness. It was hypothesized that the intervention group would demonstrate greater improvements in global cognition, hearing, and social engagement than the control group. Methods: Sixty community-dwelling older adults with mild-to-moderate ARHL were randomized 1:1 to either the ACDT group or a waitlist control group in a single-blinded pilot randomized controlled trial. Demographic data and outcome measures were collected at baseline, week 6, and week 12. Postintervention interviews were conducted to assess the feasibility and acceptability of ACDT. Results: A total of 60 participants were randomized (mean age 67.65, SD 4.78 years; 45/60, 75% male). ACDT demonstrated high feasibility and acceptability. The ACDT group showed significant improvements in focused attention (mean change=–0.15; P=. 02; d =–0.46) and divided attention (mean change=–0.21; P=. 002; d =–0.63). Significant cognitive improvements on the Hong Kong-Montreal Cognitive Assessment were identified in naming ( r =0.37; P=. 05) and visual cognition ( r =0.44; P=. 02) in the intervention group, while no significant improvements were found in the control group. Both groups reported significant decreases in emotional hearing handicap, with slightly greater improvement in the intervention group ( r =0.39; P=. 03) than in the control group ( r =0.37; P=. 04). Linear mixed model analysis revealed a small to moderate group effect (Cohen d =0.38) for 5-minute delayed recall on the Auditory Verbal Learning Test, with the fixed effects explaining 69% of the variance (marginal R² =0.69). A significant time×group interaction was observed for left-ear thresholds ( P=. 01). Qualitative analysis identified three key themes: (1) intervention coherence and participants’ affective attitude toward ACDT; (2) perceived benefits in cognition, information acquisition, and self-awareness from ACDT; and (3) perceiving ACDT as less burdensome with enhanced self-efficacy. Conclusion: Future iterations should incorporate artificial intelligence–enhanced personalization. Large-scale randomized controlled trials involving diverse samples and active control conditions are needed to confirm sustained effects on auditory and cognitive health, dual-task listening-cognitive abilities, and real-world functioning.
- 24 March 2026
- Published by Wolters Kluwer Health in Otology & Neurotology
- Vol. 47 (5) , 760-765
Conductive Hearing Loss Pathologies are Associated With Depression in the All of Us Research Program
Objective: Prior cross-sectional analysis suggests an association between conductive hearing loss (CHL) and depression. However, little is known about the potential impact of specific CHL pathologies on mood disorders. We investigate if there is an association between 3 potentially correctable causes of CHL (otosclerosis, cholesteatoma, and tympanic membrane perforation) and depressive disorders in a national cohort. Study design: Cross-sectional epidemiologic study. Setting: National Institutes of Health All of Us Research Program. Patients: Participants 18 years or older (n=363,302). Exposures were CHL pathologies defined by ICD-10 code: otosclerosis (H80.X), cholesteatoma (H71.X), and tympanic membrane perforation (H72.X). Main outcome measures: Outcomes were depressive disorders defined by ICD-10 code: major depressive disorder (MDD; F32-33) and dysthymia (F34.1). Multivariable regression, adjusting for potential confounders (age, sex, race, ethnicity, education, and smoking history), assessed the odds of depression in subjects with and without specific CHL pathologies. Results: The median age (interquartile range, range) was 57 years [41 to 69, 18 to 122]; 62% identified as female. Controlling for covariates, the odds of MDD were 1.5 times (95% CI: 1.2-1.9; P P P =0.004) higher, respectively, for those with cholesteatoma, and 2.4 times (2.2 to 2.6; P P <0.001) higher, respectively, for those with tympanic membrane perforation. Conclusions: In the All of Us dataset, all CHL pathologies were associated with MDD and most with dysthymia. This adds evidence that sensory deprivation from a purely peripheral process may impact mood.
- 24 March 2026
- Published by Wolters Kluwer Health in Otology & Neurotology
- Vol. 47 (5) , 760-765
Conductive Hearing Loss Pathologies are Associated With Depression in the All of Us Research Program
Objective: Prior cross-sectional analysis suggests an association between conductive hearing loss (CHL) and depression. However, little is known about the potential impact of specific CHL pathologies on mood disorders. We investigate if there is an association between 3 potentially correctable causes of CHL (otosclerosis, cholesteatoma, and tympanic membrane perforation) and depressive disorders in a national cohort. Study design: Cross-sectional epidemiologic study. Setting: National Institutes of Health All of Us Research Program. Patients: Participants 18 years or older (n=363,302). Exposures were CHL pathologies defined by ICD-10 code: otosclerosis (H80.X), cholesteatoma (H71.X), and tympanic membrane perforation (H72.X). Main outcome measures: Outcomes were depressive disorders defined by ICD-10 code: major depressive disorder (MDD; F32-33) and dysthymia (F34.1). Multivariable regression, adjusting for potential confounders (age, sex, race, ethnicity, education, and smoking history), assessed the odds of depression in subjects with and without specific CHL pathologies. Results: The median age (interquartile range, range) was 57 years [41 to 69, 18 to 122]; 62% identified as female. Controlling for covariates, the odds of MDD were 1.5 times (95% CI: 1.2-1.9; P P P =0.004) higher, respectively, for those with cholesteatoma, and 2.4 times (2.2 to 2.6; P P <0.001) higher, respectively, for those with tympanic membrane perforation. Conclusions: In the All of Us dataset, all CHL pathologies were associated with MDD and most with dysthymia. This adds evidence that sensory deprivation from a purely peripheral process may impact mood.
- 29 January 2026
- Published by Elsevier in Otolaryngologic Clinics of North America
- Vol. 59 (3) , 519-530
Diagnostic Tools and Imaging for Skull Base Cerebrospinal Fluid Leak
- 29 January 2026
- Published by Elsevier in Otolaryngologic Clinics of North America
- Vol. 59 (3) , 519-530
Diagnostic Tools and Imaging for Skull Base Cerebrospinal Fluid Leak
- 12 December 2025
- Published by American Speech Language Hearing Association in American Journal of Audiology
- Vol. 34 (4) , 1013-1018
Changes in Audiology Visits at an Academic Audiology Practice Following the Food and Drug Administration Over-the-Counter Hearing Aid Ruling
Purpose: In 2022, the Food and Drug Administration (FDA) permitted the sale of over-the-counter (OTC) hearing aids nationwide. The impact on audiology practice has not been well characterized. The purpose of this study is to determine if there was a change in the volume of hearing aid evaluations (HAEs) and comprehensive audiologic exams (CAEs) at an academic tertiary care audiology practice following the ruling. Method: Data were collected from the billing records of patients ≥ 18 years old. HAE and CAE visits, defined by Current Procedural Terminology and Healthcare Common Procedure Coding System codes, were included. The number of visits was totaled for equal time periods (534 days) before and after October 17, 2022, when OTC hearing aid sales began. Sensitivity analysis (365 days before and after the ruling) accounted for seasonality. Change in visits per day over the entire period was calculated from the slope of the line of best fit. Results: The mean ( SD ) age was 60.5 (18.3) years. There were 20,300 combined HAE and CAE visits. Compared to before the ruling, over the entire study period (534 days), HAE visits increased by 12.0% ( n = 57), CAE visits increased by 7.3% ( n = 685), and combined visits (HAE and CAE) increased by 7.6% ( n = 744) after the ruling. Over the entire study period (534 days), HAE had an increase of 0.084 visits/day, CAE had an increase of 4.56 visits/day, and combined visits (HAE and CAE) had an increase of 4.95 visits/day. Conclusions: The FDA OTC hearing aid ruling did not have a meaningful impact on the volume of HAEs and CAEs at an academic audiology practice. We found a small trend toward increased volume. Future studies should investigate visit patterns in other practice models to understand the full impact of the ruling on clinical audiology practice volumes.
- 12 December 2025
- Published by American Speech Language Hearing Association in American Journal of Audiology
- Vol. 34 (4) , 1013-1018
Changes in Audiology Visits at an Academic Audiology Practice Following the Food and Drug Administration Over-the-Counter Hearing Aid Ruling
Purpose: In 2022, the Food and Drug Administration (FDA) permitted the sale of over-the-counter (OTC) hearing aids nationwide. The impact on audiology practice has not been well characterized. The purpose of this study is to determine if there was a change in the volume of hearing aid evaluations (HAEs) and comprehensive audiologic exams (CAEs) at an academic tertiary care audiology practice following the ruling. Method: Data were collected from the billing records of patients ≥ 18 years old. HAE and CAE visits, defined by Current Procedural Terminology and Healthcare Common Procedure Coding System codes, were included. The number of visits was totaled for equal time periods (534 days) before and after October 17, 2022, when OTC hearing aid sales began. Sensitivity analysis (365 days before and after the ruling) accounted for seasonality. Change in visits per day over the entire period was calculated from the slope of the line of best fit. Results: The mean ( SD ) age was 60.5 (18.3) years. There were 20,300 combined HAE and CAE visits. Compared to before the ruling, over the entire study period (534 days), HAE visits increased by 12.0% ( n = 57), CAE visits increased by 7.3% ( n = 685), and combined visits (HAE and CAE) increased by 7.6% ( n = 744) after the ruling. Over the entire study period (534 days), HAE had an increase of 0.084 visits/day, CAE had an increase of 4.56 visits/day, and combined visits (HAE and CAE) had an increase of 4.95 visits/day. Conclusions: The FDA OTC hearing aid ruling did not have a meaningful impact on the volume of HAEs and CAEs at an academic audiology practice. We found a small trend toward increased volume. Future studies should investigate visit patterns in other practice models to understand the full impact of the ruling on clinical audiology practice volumes.
- 11 June 2025
- Published by Wiley in The Laryngoscope
- Vol. 135 (11) , 4341-4347
The Interaction of Multigenerational Home Environments With Hearing Loss, Cognition, and Depression
Objectives: To investigate whether the interaction between multigenerational homes and hearing loss (HL) is associated with improved cognitive and depression outcomes. Methods: This was a cross‐sectional, epidemiologic study. Data was analyzed from the 2011–2012 cycle of the National Health and Nutrition Examination Survey (NHANES) for participants 18–80 years old with audiometric data. HL was measured with the four‐frequency pure tone average in the better ear. Multigenerational homes have three or more generations or a skipped generation (i.e., < 18 and 60+). Cognition was measured with the Digital Symbol Substitution Score. Depression was measured with the PHQ‐9, both as a continuous score and a clinically significant binary variable. Multivariable regressions controlled for age, gender, and cardiovascular risk. Results: Six hundred and seventy three individuals had complete data. The mean age was 63.8 years (SD = 2.80 years) and mean HL was 18.4 dB (SD = 11.0 dB). One hundred and eight subjects lived in a multigenerational home. Among those in non‐multigenerational homes: for every 10 dB worsening of hearing, the cognitive score was 1.90 points lower (worse cognitive performance). For those in multigenerational homes: for every 10 dB worsening of hearing, the cognitive score was 1.98 points higher (better cognitive performance). There was no statistical significance of the interaction between HL and multigenerational homes on depression. Conclusions: HL was associated with worse cognition among those in non‐multigenerational homes. However, among those in multigenerational homes, HL was associated with better cognition. Future research is needed to investigate the opposite relationship between HL and cognition among those in vs. not in multigenerational homes. Level of Evidence: 3.
- 11 June 2025
- Published by Wiley in The Laryngoscope
- Vol. 135 (11) , 4341-4347
The Interaction of Multigenerational Home Environments With Hearing Loss, Cognition, and Depression
Objectives: To investigate whether the interaction between multigenerational homes and hearing loss (HL) is associated with improved cognitive and depression outcomes. Methods: This was a cross‐sectional, epidemiologic study. Data was analyzed from the 2011–2012 cycle of the National Health and Nutrition Examination Survey (NHANES) for participants 18–80 years old with audiometric data. HL was measured with the four‐frequency pure tone average in the better ear. Multigenerational homes have three or more generations or a skipped generation (i.e., < 18 and 60+). Cognition was measured with the Digital Symbol Substitution Score. Depression was measured with the PHQ‐9, both as a continuous score and a clinically significant binary variable. Multivariable regressions controlled for age, gender, and cardiovascular risk. Results: Six hundred and seventy three individuals had complete data. The mean age was 63.8 years (SD = 2.80 years) and mean HL was 18.4 dB (SD = 11.0 dB). One hundred and eight subjects lived in a multigenerational home. Among those in non‐multigenerational homes: for every 10 dB worsening of hearing, the cognitive score was 1.90 points lower (worse cognitive performance). For those in multigenerational homes: for every 10 dB worsening of hearing, the cognitive score was 1.98 points higher (better cognitive performance). There was no statistical significance of the interaction between HL and multigenerational homes on depression. Conclusions: HL was associated with worse cognition among those in non‐multigenerational homes. However, among those in multigenerational homes, HL was associated with better cognition. Future research is needed to investigate the opposite relationship between HL and cognition among those in vs. not in multigenerational homes. Level of Evidence: 3.
- 19 May 2025
- Published by Wiley in The Laryngoscope
- Vol. 135 (10) , 3840-3849
Associations Between Hearing Loss and Dementia in a Large Electronic Health Record System
Objectives: Epidemiologic analyses of hearing loss utilize national volunteer‐based datasets that are restricted by limited variables and few individuals with severe disease. We overcome these limitations using two large electronic health records to study whether audiometric hearing loss is associated with dementia.Methods: This was a cross‐sectional, multicentered retrospective study using the electronic health records at the academic medical centers of Columbia University and Cornell University (n = 31,997 total) for participants ≥ 18 years old with clinical audiometry from February 1, 2020 through May 5, 2023. Hearing measures were from the better ear and included pure tone average, word recognition score, and speech reception threshold. Dementia was defined as ICD‐10 diagnosis code only, dementia medications only, the presence of both conditions, and the presence of either condition. Odds ratios were computed from univariable and multivariable logistic regressions between hearing loss and dementia with 95% confidence intervals, using the covariates of age, sex, cardiovascular risk score, and site.Results: The mean age (SD) in the combined dataset was 60.5 (18.3) years and 18,992 (59.4%) were women. All univariable regressions showed increased odds of dementia with worsening hearing, regardless of how hearing or dementia was defined. Controlling for covariates, for every 10‐dB worsening in hearing by pure tone audiometry, the odds of dementia (as defined by ICD‐code or medication list) increased by 1.11 times (95% CI = 1.07–1.16); for every 10% worsening in word recognition score, the odds of dementia increased by 1.06 times (95% CI = 1.01–1.11); for every 10‐dB worsening of the speech reception threshold, the odds of dementia increased by 1.10 times (95% CI = 1.05–1.15).Conclusions: Using a large electronic health record system, audiometric hearing loss defined in three separate ways was associated with increased odds of dementia. Electronic health records can corroborate and expand previously studied relationships between hearing loss and its comorbidities, including dementia.Level of Evidence: 3.
- 19 May 2025
- Published by Wiley in The Laryngoscope
- Vol. 135 (10) , 3840-3849
Associations Between Hearing Loss and Dementia in a Large Electronic Health Record System
Objectives: Epidemiologic analyses of hearing loss utilize national volunteer‐based datasets that are restricted by limited variables and few individuals with severe disease. We overcome these limitations using two large electronic health records to study whether audiometric hearing loss is associated with dementia.Methods: This was a cross‐sectional, multicentered retrospective study using the electronic health records at the academic medical centers of Columbia University and Cornell University (n = 31,997 total) for participants ≥ 18 years old with clinical audiometry from February 1, 2020 through May 5, 2023. Hearing measures were from the better ear and included pure tone average, word recognition score, and speech reception threshold. Dementia was defined as ICD‐10 diagnosis code only, dementia medications only, the presence of both conditions, and the presence of either condition. Odds ratios were computed from univariable and multivariable logistic regressions between hearing loss and dementia with 95% confidence intervals, using the covariates of age, sex, cardiovascular risk score, and site.Results: The mean age (SD) in the combined dataset was 60.5 (18.3) years and 18,992 (59.4%) were women. All univariable regressions showed increased odds of dementia with worsening hearing, regardless of how hearing or dementia was defined. Controlling for covariates, for every 10‐dB worsening in hearing by pure tone audiometry, the odds of dementia (as defined by ICD‐code or medication list) increased by 1.11 times (95% CI = 1.07–1.16); for every 10% worsening in word recognition score, the odds of dementia increased by 1.06 times (95% CI = 1.01–1.11); for every 10‐dB worsening of the speech reception threshold, the odds of dementia increased by 1.10 times (95% CI = 1.05–1.15).Conclusions: Using a large electronic health record system, audiometric hearing loss defined in three separate ways was associated with increased odds of dementia. Electronic health records can corroborate and expand previously studied relationships between hearing loss and its comorbidities, including dementia.Level of Evidence: 3.
- 27 January 2025
- Published by Wiley in The Laryngoscope
- Vol. 135 (6) , 2107-2111
Hearing Loss and Discrimination: Evidence of Intersectionality in the All of Us Research Program
Objectives: Hearing loss (HL) has significant implications on social functioning. Here, we study the relationship between HL, race, and these combined categories as risk factors for discrimination in the large national All of Us cohort.Methods: The National Institutes of Health All of Us dataset was analyzed after including individuals who completed the Everyday Discrimination Survey between November 2021 and January 2022. HL and potential medical confounders were defined per ICD‐10 codes or demographics. Multivariable linear regressions analyzing the relationship between HL and discrimination were adjusted for potential confounders, including age, gender, race, ethnicity, other demographic factors, and relevant medical conditions, such as depression and dementia. Additional regressions were conducted to evaluate how combined HL and race categories associated with discrimination risk.Results: Totally 8,722 individuals ≥18 years old had complete data. The mean age was 65 years (SD = 13.0 years), and 41% were women. Individuals with HL, compared with those without, were more likely to report discrimination in six out of nine questions on the Everyday Discrimination Survey (p < 0.05, with effect sizes ranging from −0.05 to −0.16 on a 6‐point scale from 0 = “Almost everyday” to 5 = “Never”). Notably, for four out of those six questions, combined Black race and HL was associated with a risk of discrimination independent from the risk conveyed by race and/or HL individually.Conclusions: This study offers evidence of HL as a risk factor for self‐reported discrimination. Further, this study provides support for an intersectional understanding between discrimination, race, and HL.Level of Evidence: 3 Laryngoscope, 135:2107–2111, 2025
- 27 January 2025
- Published by Wiley in The Laryngoscope
- Vol. 135 (6) , 2107-2111
Hearing Loss and Discrimination: Evidence of Intersectionality in the All of Us Research Program
Objectives: Hearing loss (HL) has significant implications on social functioning. Here, we study the relationship between HL, race, and these combined categories as risk factors for discrimination in the large national All of Us cohort.Methods: The National Institutes of Health All of Us dataset was analyzed after including individuals who completed the Everyday Discrimination Survey between November 2021 and January 2022. HL and potential medical confounders were defined per ICD‐10 codes or demographics. Multivariable linear regressions analyzing the relationship between HL and discrimination were adjusted for potential confounders, including age, gender, race, ethnicity, other demographic factors, and relevant medical conditions, such as depression and dementia. Additional regressions were conducted to evaluate how combined HL and race categories associated with discrimination risk.Results: Totally 8,722 individuals ≥18 years old had complete data. The mean age was 65 years (SD = 13.0 years), and 41% were women. Individuals with HL, compared with those without, were more likely to report discrimination in six out of nine questions on the Everyday Discrimination Survey (p < 0.05, with effect sizes ranging from −0.05 to −0.16 on a 6‐point scale from 0 = “Almost everyday” to 5 = “Never”). Notably, for four out of those six questions, combined Black race and HL was associated with a risk of discrimination independent from the risk conveyed by race and/or HL individually.Conclusions: This study offers evidence of HL as a risk factor for self‐reported discrimination. Further, this study provides support for an intersectional understanding between discrimination, race, and HL.Level of Evidence: 3 Laryngoscope, 135:2107–2111, 2025
- 26 January 2025
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 172 (4) , 1262-1271
The Association Between Hearing Loss and Depression in a Large Electronic Health Record System
Objective: Hearing loss (HL) is associated with depression, but existing datasets are limited by the type of data available for both hearing and mental health conditions. The purpose of this study is to determine if there is an association between HL and depressive disorders within a large bi‐institutional electronic health record (EHR) system containing more granular diagnostic information.Study Design: Cross‐sectional epidemiologic study.Setting: Two academic medical centers.Methods: Audiometric data was collected from patients ≥18 years old between 2020 to mid‐2023 (n = 29,772). The exposure was HL defined as the 4‐frequency pure‐tone average (PTA), speech reception threshold (SRT), and word recognition score (WRS). The outcomes were depression, categorized as either: (1) major depressive disorder, defined by International Classification of Diseases, 10th Revision (ICD‐10) code; (2) persistent mood disorder, defined by ICD‐10 code; or (3) antidepressant medication use, defined by medication lists. Odds ratios were computed from logistic regressions between HL and each of the outcome variables, controlling for age, sex, cardiovascular risks, and site.Results: The mean age (standard deviation) was 60.5 (18.2) years, and 17,736 participants (59.6%) were female. Controlling for covariates, for every 10‐dB worsening in hearing by PTA, the odds of major depressive disorder increased by 1.04 times (95% confidence interval [CI] = 1.01‐1.07, P = .015). Similarly, for every 10 dB worsening in hearing by PTA or SRT, the odds of antidepressant medication use increased by 1.04 times (95% CI = 1.01‐1.06, P = .004). Odds ratios for persistent mood disorder were nonsignificant.Conclusion: In a large academic EHR, HL is associated with major depressive disorder and antidepressant medication use.
- 26 January 2025
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 172 (4) , 1262-1271
The Association Between Hearing Loss and Depression in a Large Electronic Health Record System
Objective: Hearing loss (HL) is associated with depression, but existing datasets are limited by the type of data available for both hearing and mental health conditions. The purpose of this study is to determine if there is an association between HL and depressive disorders within a large bi‐institutional electronic health record (EHR) system containing more granular diagnostic information.Study Design: Cross‐sectional epidemiologic study.Setting: Two academic medical centers.Methods: Audiometric data was collected from patients ≥18 years old between 2020 to mid‐2023 (n = 29,772). The exposure was HL defined as the 4‐frequency pure‐tone average (PTA), speech reception threshold (SRT), and word recognition score (WRS). The outcomes were depression, categorized as either: (1) major depressive disorder, defined by International Classification of Diseases, 10th Revision (ICD‐10) code; (2) persistent mood disorder, defined by ICD‐10 code; or (3) antidepressant medication use, defined by medication lists. Odds ratios were computed from logistic regressions between HL and each of the outcome variables, controlling for age, sex, cardiovascular risks, and site.Results: The mean age (standard deviation) was 60.5 (18.2) years, and 17,736 participants (59.6%) were female. Controlling for covariates, for every 10‐dB worsening in hearing by PTA, the odds of major depressive disorder increased by 1.04 times (95% confidence interval [CI] = 1.01‐1.07, P = .015). Similarly, for every 10 dB worsening in hearing by PTA or SRT, the odds of antidepressant medication use increased by 1.04 times (95% CI = 1.01‐1.06, P = .004). Odds ratios for persistent mood disorder were nonsignificant.Conclusion: In a large academic EHR, HL is associated with major depressive disorder and antidepressant medication use.
- 20 July 2024
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 45 (5) , 104403
Age-based disparities in hearing loss diagnosis and treatment in the United States population
- 20 July 2024
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 45 (5) , 104403
Age-based disparities in hearing loss diagnosis and treatment in the United States population